UnitedHealth Group Statement on: The UnitedHealth Group and NHLBI Collaborating Centers of Excellence (COEs) Network
* Reuters is not responsible for the content in this press release.
MINNEAPOLIS--(Business Wire)-- UnitedHealth Group President, Global Health, Simon Stevens released the following statement: "We are delighted that the National Heart, Lung and Blood Institute (NHLBI) has joined with UnitedHealth Group`s Chronic Disease Initiative in establishing the `UnitedHealth Group and NHLBI Collaborating Centers of Excellence` (COEs). This worldwide network of research and training centers will build institutional and community capacity to prevent and control chronic diseases, such as cardiovascular, lung diseases and diabetes. Unless we make chronic disease prevention a worldwide priority, the personal, social, economic and political consequences will reverberate throughout the globe. The time has come to increase resources to counter the pandemic of chronic disease sweeping through low- and middle-income countries." To interview a UnitedHealth Group spokesperson, contact Marti Jones at 952-931-5490 or martha_jones@uhc.com. Information on all of the UnitedHealth Group and the NHLBI Collaborating Centers of Excellence can be found on the NHLBI Global Health Initiative Web site, www.globalhealth.nhlbi.nih.gov (to go live at 6:30 p.m. EDT on June 10). Information on UnitedHealth Group can be found at www.unitedhealthgroup.com. About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to making health care work better. Headquartered in Minneapolis, Minn., UnitedHealth Group offers a broad spectrum of products and services through six operating businesses: UnitedHealthcare, Ovations, AmeriChoice, OptumHealth, Ingenix, and Prescription Solutions. Through its family of businesses, UnitedHealth Group serves more than 70 million individuals nationwide. UnitedHealth Group Marti Jones, 952-931-5490 Martha_jones@uhc.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters